Free Trial

INVO Bioscience Q2 2024 Earnings Report

INVO Bioscience logo
$0.75 -0.01 (-1.32%)
(As of 12/20/2024 ET)

INVO Bioscience EPS Results

Actual EPS
-$0.62
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

INVO Bioscience Revenue Results

Actual Revenue
$1.84 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

INVO Bioscience Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol

INVO Bioscience Earnings Headlines

INVO Bioscience (NASDAQ:INVO) Trading Down 3.9% - Here's Why
NAYA Biosciences to present insights into mode of action of NY-303
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
NAYA Biosciences Inc (INVO)
See More INVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Bioscience and other key companies, straight to your email.

About INVO Bioscience

INVO Bioscience (NASDAQ:INVO), together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

View INVO Bioscience Profile

More Earnings Resources from MarketBeat

Upcoming Earnings